Currently, there are 660.73M common shares owned by the public and among those 129.76M shares have been available to trade.
The company’s stock has a 5-day price change of -12.00% and -19.79% over the past three months. OLPX shares are trading -39.37% year to date (YTD), with the 12-month market performance down to -57.10% lower. It has a 12-month low price of $1.19 and touched a high of $4.26 over the same period. OLPX has an average intraday trading volume of 2.05 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -11.38%, -2.98%, and -18.98% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Olaplex Holdings Inc (NASDAQ: OLPX) shares accounts for 18.10% of the company’s 660.73M shares outstanding.
It has a market capitalization of $1.02B and a beta (3y monthly) value of 2.41. The stock’s trailing 12-month PE ratio is 21.45, while the earnings-per-share (ttm) stands at $0.07. The company has a PEG of 3.52 and a Quick Ratio of 9.12 with the debt-to-equity ratio at 0.76. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.37% over the week and 7.14% over the month.
Earnings per share for the fiscal year are expected to decrease by -10.53%, and 19.17% over the next financial year. EPS should grow at an annualized rate of 6.10% over the next five years, compared to -0.81% over the past 5-year period.
Looking at the support for the OLPX, a number of firms have released research notes about the stock. Piper Sandler stated their Neutral rating for the stock in a research note on March 19, 2024, with the firm’s price target at $1.25-$2. Piper Sandler was of a view on August 25, 2023 that the stock is Underweight, while Canaccord Genuity gave the stock Hold rating on August 11, 2023, issuing a price target of $5- $3. Telsey Advisory Group on their part issued Market Perform rating on August 09, 2023.
